Compare NUTX & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUTX | CERT |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | United States | United States |
| Employees | 944 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2009 | 2020 |
| Metric | NUTX | CERT |
|---|---|---|
| Price | $193.24 | $7.94 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $252.50 | $11.67 |
| AVG Volume (30 Days) | 135.6K | ★ 2.4M |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 7.93 | ★ 87.50 |
| EPS | ★ 15.87 | N/A |
| Revenue | ★ $875,257,000.00 | $418,838,000.00 |
| Revenue This Year | $6.12 | $4.18 |
| Revenue Next Year | $4.04 | $5.39 |
| P/E Ratio | $12.26 | ★ N/A |
| Revenue Growth | ★ 82.36 | 8.75 |
| 52 Week Low | $80.53 | $4.45 |
| 52 Week High | $204.00 | $13.88 |
| Indicator | NUTX | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 60.84 | 54.73 |
| Support Level | $142.71 | $7.86 |
| Resistance Level | $204.00 | $8.39 |
| Average True Range (ATR) | 8.54 | 0.32 |
| MACD | -0.23 | -0.06 |
| Stochastic Oscillator | 77.16 | 34.31 |
Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.